Background
Population studies reporting contemporary long-term outcomes following catheter ablation of atrial fibrillation (AF) are sparse.
Objective
To evaluate long-term clinical outcomes following AF ablation and examine variation in outcomes by age, sex, and the presence of heart failure.
Methods and Results
We identified 30,601 unique patients (mean age 62.7±11.8y, 30.0% female) undergoing AF ablation from 2008-17 in Australia and New Zealand using nation-wide hospitalisation data. The primary outcomes were all-cause mortality; and re-hospitalisations for AF or flutter, repeat AF ablation, and cardioversion. Secondary outcomes were re-hospitalisations for other cardiovascular events. During 124,858.7 person-years of follow-up, 1,900 patients died (incident rate 1.5/100 person-years) with a survival probability of 93.0% (95%CI 92.6%-93.4%) by 5 years and 84.0% (95%CI 82.4%-85.5%) by 10 years. Re-hospitalisations for AF or flutter (13.3/100 person-years), repeat ablation (5.9/100 person-years), and cardioversion (4.5/100 person-years) were common with respective cumulative incidence of 49.4% (95%CI 48.4%-50.4%), 28.1% (95%CI 27.2%-29.0%), and 24.4% (95%CI 21.5%-27.5%) at 10-years post-ablation. Re-hospitalisations for stroke (0.7/100 person-years), heart failure (1.1/100 person-years), acute myocardial infarction (0.4/100 person-years), syncope (0.6/100 person-years), other arrhythmias (2.5/100 person-years), and new cardiac device implantation (2.0/100 person-years) occurred less frequently. Elderly patients and those with comorbid heart failure had worse survival but were less likely to undergo repeat ablation, while long-term outcomes were comparable between sex.
Conclusion
Patients undergoing AF ablations had good long-term survival, a low incidence of re-hospitalisations for stroke or heart failure, and about half remained free of re-hospitalisations for AF or flutter, including for repeat AF ablation, or cardioversion.